Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 22,450 |
| Receivables | N/A | N/A | N/A | 180 |
| Other current assets | 0 | 0 | 0 | 740 |
| TOTAL | $N/A | $N/A | $N/A | $23,370 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 0 | 160 |
| TOTAL | $N/A | $N/A | $N/A | $160 |
| Total Assets | $N/A | $N/A | $N/A | $24,060 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | N/A | 2,190 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 800 |
| Accrued Expenses | N/A | N/A | N/A | 3,970 |
| TOTAL | $N/A | $N/A | $N/A | $6,970 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | N/A | 5,550 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 300 |
| TOTAL | $N/A | $N/A | $N/A | $5,850 |
| Total Liabilities | $N/A | $N/A | $N/A | $12,830 |
| Shareholders' Equity | ||||
| Retained earnings | N/A | N/A | N/A | -74,990 |
| Other shareholders' equity | 0 | 0 | 0 | 79,830 |
| TOTAL | $N/A | $N/A | $N/A | $11,230 |
| Total Liabilities And Equity | $0 | $0 | $0 | $24,060 |